Expiration date: 06/2025

Composition: 

levetiracetam 250, 500 or 1000 mg

Excipients: crospovidone, povidone, colloidal silicon dioxide, magnesium stearate

Indications:

As monotherapy: partial seizures with secondary generalization or without patients 16 years of age with newly diagnosed epilepsy. As an adjuvant therapy for the treatment of the following conditions: partial seizures with secondary generalization in patients without epilepsy 6 years

myoclonic seizures in patients with juvenile myoclonic epilepsy 12 years

primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy with 12 years.